A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five years of follow-up, according to a study published in Nature Medicine.

Pro-Trump economist Steve Moore presented unpublished Census Bureau data from the Oval Office claiming the Biden administration inflated job growth numbers during its final two years.

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. | Pfizer has jettisoned yet ...